Letters to the Editor
Comment on: Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver
W. Wang1, J. Wang2
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao; Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang; Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Science, Beijing, China. jack1987168@163.com
- Department of Oncology, Luzhou People’s Hospital, Luzhou, Sichuan, China.
CER16342
2023 Vol.41, N°3
PI 0762
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 36622108 [PubMed]
Received: 07/11/2022
Accepted : 30/11/2022
In Press: 04/01/2023
Published: 23/03/2023